Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 05, 2020

SELL
$22.38 - $54.06 $140,143 - $338,523
-6,262 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$51.85 - $73.36 $414 - $586
8 Added 0.13%
6,262 $325,000
Q3 2019

Nov 01, 2019

SELL
$40.05 - $57.47 $358,207 - $514,011
-8,944 Reduced 58.85%
6,254 $343,000
Q1 2019

Apr 24, 2019

BUY
$29.37 - $40.49 $37,887 - $52,232
1,290 Added 9.28%
15,198 $460,000
Q4 2018

Feb 01, 2019

BUY
$30.16 - $43.0 $111,712 - $159,272
3,704 Added 36.3%
13,908 $467,000
Q2 2018

Jul 20, 2018

SELL
$28.77 - $48.27 $374 - $627
-13 Reduced 0.13%
10,204 $327,000
Q1 2018

Apr 18, 2018

BUY
$49.22 - $68.43 $97,849 - $136,038
1,988 Added 24.16%
10,217 $508,000
Q4 2017

Jan 17, 2018

BUY
$52.14 - $59.94 $429,060 - $493,246
8,229
8,229 $444,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $261M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.